What are the Uppsala Antibiotic Days?
The Uppsala Antibiotic Days conference has been established with the goal of creating a forum to support scientific exchange amongst local, national and international experts on antimicrobial resistance (AMR). There is consensus that AMR constitutes a multifaceted issue which poses a substantial threat to the health and prosperity of communities worldwide. As experts on this topic, we recognize that any tangible and lasting solution to this so-called “silent pandemic” will require expertise from an equally multidisciplinary faculty.
Uppsala’s unique position as a European hub for research and innovation, in particular AMR, makes the city an excellent venue where scientists, clinicians, and members of the public can gather to share meaningful ideas about the topic. We encourage attendees to submit abstracts for the opportunity to present their scientific discoveries. While the conference’s primary directive leans towards those working directly within the field, we also welcome members of the broad scientific community and general public who wish to participate in the discussion.
While we prepare the programme for our 2024 edition, you can get inspired by checking out our previous programme, or get to know our 2024 speaker's line up
Conference topics
Is this conference for you? Organized by thematic sessions,
the Uppsala Antibiotic Days will host talks on an array of AMR topics:
Drug discovery & Economics
After the golden era of antibiotics, we have been facing a dry pipeline for decades. Here we will examine what is the current situation of the discovery of new antimicrobial drugs and the aspects of financing and economics in this area.
Social Sciences & Education
With behaviour and human action as key aspects of AMR, we will talk in this session about how research on social sciences and education are part of the solution.
Diagnostics
To ensure proper and timely antimicrobial treatment rapid and affordable diagnostics and strain analysis are needed. Here we will explore the latest research and innovation in this area.
The Future of Clinical Trials
With new drugs and treatments in the pipeline, how do we ensure a proper evaluation of their clinical relevance? In this session, we will explore the transformative landscape of clinical trials, with a particular emphasis on the future of evaluating new anti-infective agents.
One Health
Looking at AMR from a One Health perspective, here we will talk about the joint effort of various disciplines that come together to provide solutions for human, animal, and environmental health
Emerging AMR Pathogens
New resistant pathogens are emerging, including new bacterial species, viruses, fungi, and parasites. Here we will explore resistance with an outlook to the future.